معرفی
Dr. Richard Noble is a researcher at Newcastle University, specializing in cancer biology and pharmacology. His work focuses on molecular targeting of oncogenic pathways, particularly EGFR inhibition, ERK5 kinase modulation, and MDM2-p53 interactions, with emphasis on covalent drug design and metabolic vulnerabilities in lymphomas.
Research Interests
- Covalent binding strategies for irreversible enzyme inhibition
- Targeted cancer therapies via kinase and receptor modulation
- Metabolic pathway disruption in B-cell lymphomas
- Development of imaging probes for cellular dynamics
- Pharmacokinetic optimization of anticancer agents
- Molecular mechanisms of drug resistance
Key Publications
Recent studies (2025-2017) explore chiral influences on EGFR inhibition, dual targeting of glycolysis and oxidative phosphorylation, and the design of click-compatible probes for MDM2 visualization. His work bridges medicinal chemistry and translational oncology.
۰مقاله ثبتشده